Author: Nancy Humphrey

The study found that some children with mystery digestive symptoms may actually have undiagnosed alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.

Children’s mystery symptoms may be alpha-gal syndrome

Apr. 13, 2023—A Vanderbilt study found that some children with mystery digestive symptoms may actually have undiagnosed alpha-gal syndrome, commonly known as the red meat allergy linked to tick bites.

VUMC-led trial shows two investigational drugs are ineffective for treating severe COVID-19

Apr. 11, 2023—A Vanderbilt-led study evaluating two investigational drugs to treat severe COVID-19 demonstrated that neither drug was effective.

On hand for a recent celebration of the new research fund were Debra Friedman, MD, MS, left, and Brianna Smith, MD, MS, (holding the plaque) and, from right, Larisa and Phillip Featherstone with their daughters Lily, Sophie and Sophia, and Carol and Ron Johnston.

Family’s gift will support pediatric cancer research

Mar. 30, 2023—Lily Hensiek's family has made a new $1 million commitment to endow the Lily’s Garden Discovery Researcher Fund in the Division of Pediatric Hematology and Oncology in the Department of Pediatrics at Vanderbilt University Medical Center.

VUMC accredited for primary ciliary dyskinesia care

Mar. 23, 2023—Vanderbilt University Medical Center has been named a fully accredited adult PCD (primary ciliary dyskinesia) Foundation Clinical and Research Center site.

Review explores ICU-related cognitive impact scores

Feb. 23, 2023—A recent systematic review by Vanderbilt researchers has taken a close look at the cognitive instruments used in long-term outcome studies of survivors of adult critical illness and how those test scores are interpreted.

Study of two sepsis interventions finds identical outcomes

Feb. 2, 2023—Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection.

Liz and John Potocsnak, second and third from left, with Jeff Balser, MD, PhD, left, Rizwan Hamid, MD, PhD, and Jennifer Pietenpol, PhD.

Potocsnak family’s transformative gift creates Center for Undiagnosed and Rare Disorders

Feb. 2, 2023—A transformative gift from the Potocsnak family has established the Potocsnak Center for Undiagnosed and Rare Disorders at Vanderbilt University Medical Center.

Matthew Semler, MD, MSc, and Cheryl Gatto, PhD, will lead the new Center for Learning Healthcare.

VUMC establishes novel Center for Learning Healthcare

Jan. 26, 2023—Vanderbilt University Medical Center has established a first-of-its-kind Center for Learning Healthcare that will bring together clinicians, health system operations leaders and researchers to generate evidence in the course of health care delivery to continuously improve the quality, value and safety of health care offered to patients.

Vanderbilt mourns loss of ASAP co-founder Murray

Jan. 20, 2023—John Joseph Murray V, MD, PhD, a co-founder of the Vanderbilt University Medical Center Asthma, Sinus and Allergy Program (ASAP), died on Jan. 6 at Vanderbilt University Hospital.

Kathryn Edwards, MD, spoke at a recent event celebrating her career.

Infectious disease expert Edwards ends storied career

Jan. 5, 2023—Vanderbilt's Kathryn Edwards, MD, internationally recognized for her countless contributions to vaccine evaluation and implementation, public health advocacy, and the mentorship and training of new generations of experts in infectious disease over the past four decades, retired on Dec. 31, 2022.

Study to explore nasal bacteria of children born by C-section

Nov. 10, 2022—Vanderbilt is recruiting pregnant women scheduled to undergo a repeat cesarean section at VUMC for a study of potential interventions to change the bacteria living in the nose of children born by C-section.

Lori Ann Kehler, OD, gives a low vision exam to patient Mary Elizabeth Parker at the Vanderbilt Eye Institute.

Low vision initiative for children lands new funding

Oct. 27, 2022—Vanderbilt's Project PAVE has received funding from the Tennessee Department of Intellectual and Developmental Disabilities to continue the program that has provided low-vision evaluations for more than 2,150 school-age children in Tennessee since 1993.